GE HealthCare Technologies Inc.
GE HealthCare Technologies
GEHC · NASDAQ
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $20.6B
- Assets
- $36.9B
- SEC filing
- DEF 14A
- Filed
- March 19, 2026
Executive Compensation
Compensation reported for GE HealthCare Technologies’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Peter J. Arduini
President and CEO
$18.6M
Reported total
- Salary
- $0
- Stock awards
- $11,249,533
- Incentives
- $3,406,067
- Option awards
- $3,624,970
- Other
- $282,224
Taha Kass-Hout
Chief Science And Technology Officer
$6M
Reported total
- Salary
- $0
- Stock awards
- $3,250
- Incentives
- $1,897,102
- Option awards
- $3,103,254
- Other
- $1,002,223
James Saccaro
VP and CFO
$5.9M
Reported total
- Salary
- $0
- Stock awards
- $890,415
- Incentives
- $974,978
- Option awards
- $3,025,712
- Other
- $1,002,233
Frank Jimenez
General Counsel And Corporate Secretary
$5.5M
Reported total
- Salary
- $0
- Stock awards
- $890,415
- Incentives
- $874,977
- Option awards
- $2,715,368
- Other
- $1,017,310
Jeannette Bankes
President and CEO, Patient Care Solutions
$5.4M
Reported total
- Salary
- $0
- Stock awards
- $160,000
- Incentives
- $939,918
- Option awards
- $3,722,658
- Other
- $535,727
Peter J. Arduini
President and CEO
$18.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 19, 2026.
- Salary
- $0
- Stock Awards
- $11.2M
- Option Awards
- $3.6M
- Incentives
- $3.4M
- Other
- $282K
Historical Compensation
Peter J. Arduini total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $0 | $11,249,533 | $18,562,794 |
| 2024 | $0 | $1,282,427 | $19,487,880 |
| 2023 | $0 | $12,705,850 | $24,510,947 |
Named Executive Officers
Peter J. Arduini
President and CEO
GE HealthCare Technologies · GEHC
$18.6M
FY 2025 · DEF 14A
James Saccaro
VP and CFO
GE HealthCare Technologies · GEHC
$5.9M
FY 2025 · DEF 14A
Taha Kass-Hout
Chief Science And Technology Officer
GE HealthCare Technologies · GEHC
$6M
FY 2025 · DEF 14A
Frank Jimenez
General Counsel And Corporate Secretary
GE HealthCare Technologies · GEHC
$5.5M
FY 2025 · DEF 14A
Jeannette Bankes
President and CEO, Patient Care Solutions
GE HealthCare Technologies · GEHC
$5.4M
FY 2025 · DEF 14A
Source information
- Company
- GE HealthCare Technologies Inc.
- Ticker
- GEHC · NASDAQ
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 19, 2026
- SEC accession number
- 0001932393-26-000021
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →